BENDAMUSTINE HYDROCHLORIDE — all Canadian products
18 DINs
14 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BENDAMUSTINE HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02509261 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Marketed | |
| 02526972 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Approved | |
| 02496852 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02496860 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Marketed | |
| 02542005 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Marketed | |
| 02541998 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02526980 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Approved | |
| 02509253 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02524309 | BENVYON | PFIZER CANADA ULC | Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02527073 | ESAMUZE | DR REDDY'S LABORATORIES LTD | Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 45 MG | Approved | |
| 02496887 | NAT-BENDAMUSTINE | NATCO PHARMA (CANADA) INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02496895 | NAT-BENDAMUSTINE | NATCO PHARMA (CANADA) INC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Marketed | |
| 02392550 | TREANDA | TEVA CANADA LIMITED | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Marketed | |
| 02392569 | TREANDA | TEVA CANADA LIMITED | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Marketed | |
| 02509172 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Dormant | |
| 02509164 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Dormant | |
| 02498111 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 02498103 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | Intravenous | BENDAMUSTINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
Browse other molecules: